Generic pharmaceutical products provider Lannett Company (LCI) is a puzzle. Lannett shares jumped as much as 50% today, before trimming back some gains …
Lannett Company, Inc. (NYSE:LCI) is cashing in on the demand for generic drugs.
In a research report released today, Oppenheimer analyst Rohit Vanjani reiterated a Perform rating on Lannett Company (NYSE:LCI), while no price target was …
Roth Capital analyst Scott Henry maintained a Buy rating on Lannett Company (NYSE:LCI) with a price target of $66, as the company reported FY1Q15 …
In a research report issued today, Oppenheimer analyst Rohit Vanjani maintained an Outperform rating on Lannett Company (NYSE:LCI) and slightly raised his price …
In a research report issued today, Roth Capital analyst Scott Henry maintained a Buy rating on Lannett Company (NYSE:LCI) and raised his price …
In a report published today, Roth Capital analyst Scott Henry maintained a Buy rating on Lannett Company (LCI) with a $45 price target, after the company announced that it expects …
In a research report released today, Canaccord analyst John Newman reiterated coverage with a Buy rating on Lannett Company (LCI), and a $55.00 price target.
In a report published today, Roth Capital analyst Scott Henry maintained a Buy rating on Lannett Company (LCI) with a $45 price target, …
In a research note issued earlier today, Canaccord analyst John Newman reiterated coverage with a “Buy” rating on Lannett Company, Inc. (LCI), and a …
